CLDN1 and metabolic dysfunction-associated steatotic liver disease: As shown in Figure 3b, the RT-qPCR results showed that the relative expression of claudin-1 in the NAFLD group was significantly reduced compared with the normal group (0.23 ± 0.21, p < 0.05).